( July 23, 2025, 2:34 PM EDT) -- SAN FRANCISCO — A federal judge in California granted final approval to a $27.5 million settlement among a pharmaceutical company, its former chief executive and shareholders who alleged that the company entered into a merger and sale to its largest shareholder significantly lower than its fair value, in violation of federal securities law....